Search Results 241-250 of 19303 for prostate cancer
Prostate cancer cells make excessive amounts of this protein, so an elevated or increasing PSA level is a possible sign of prostate cancer. That said, the ...
... prostate cancer, he chose Mayo Clinic for his minimally invasive treatment. A collaborative team that included urologists and oncologists developed just the ...
... prostate cancer this year. While most forms of prostate cancer run an indolent course, metastatic castration-resistant prostate cancer (mCRPC) has an ...
A Study of Apalutamide in Participants With High‑Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy · Overview.
By looking at the genetic makeup of individual men with prostate cancer, Mayo Clinic is helping doctors know which drugs may help. Chemotherapy and hair loss: ...
“Prostate cancer is one of the most common types of cancer in men. If detected early when it is confined to the prostate, treatment can be more successful.
Clinicians inform men ages 55 to 69 years about the potential benefits and harms of screening for prostate cancer based on prostate-specific antigen. Many ...
The purpose of this study is to determine how patients with metastatic castration-resistant prostate cancer, and evidence of a homologous recombination gene ...
A Study of Bladder Filling Variations During Radiation Therapy in Patients Undergoing Radiation Treatment for Prostate Cancer · Overview · Participation ...
Participation eligibility · Men at least 18 years of age referred with clinical suspicion of prostate cancer. · Serum PSA ≤ 20ng/ml. · Fit to undergo all ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Benefactor support fuels Mayo Clinic’s groundbreaking research. Make a gift today to help us save lives.